Items where authors include "Tachdjian, R."

Article

Banerji, A., Craig, T., Sitz, K. et al. (21 more authors) (2026) Open-label phase 1b/2 trial of navenibart, a long-acting plasma kallikrein inhibitor for hereditary angioedema. The Journal of Allergy and Clinical Immunology, 157 (5). 1127-1135.e6. ISSN 0091-6749

Tachdjian, R., Savic, S. orcid.org/0000-0001-7910-0554, Fridman, M. et al. (3 more authors) (2024) Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks. Allergy and Asthma Proceedings, 45 (1). pp. 37-43. ISSN 1088-5412

Conference abstract

Tachdjian, R., Savic, S. orcid.org/0000-0001-7910-0554, Fridman, M. et al. (3 more authors) (2022) REAL-WORLD TREATMENT BURDEN ASSOCIATED WITH PARENTERAL ON-DEMAND THERAPIES FOR HEREDITARY ANGIOEDEMA. [Conference abstract]